This study evaluated a partial MHC/neuroantigen peptide construct (RTL551; pI-Ab/mMOG-35-55), as a novel treatment strategy for methamphetamine induced cognitive impairments. The gene discussed is HLA-C; the disease is Cognitive impairment.